Related Experiment Video
Updated: Jun 23, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Advances in antiretroviral therapy
Timothy J Wilkin1, Barbara Taylor, Susan Olender
1Weill Medical College of Cornell University, New York, NY, USA.
Summary
The 16th Conference on Retroviruses and Opportunistic Infections highlighted advances in HIV-1 treatment and prevention. Key findings included new antiretroviral drugs and interleukin-2 trial results for patients with low CD4 counts.
Area of Science:
- Infectious Diseases
- Immunology
- Virology
Background:
- The 16th Conference on Retroviruses and Opportunistic Infections (CROI) is a premier scientific meeting.
- It focuses on the latest research in human immunodeficiency virus type 1 (HIV-1) and associated opportunistic infections.
- The conference serves as a critical platform for disseminating cutting-edge findings in antiretroviral therapy (ART).
Framework:
- The conference presented new data on investigational antiretroviral drugs.
- Management strategies for both treatment-naive and treatment-experienced HIV-1 patients were discussed.
- The use of antiretroviral drugs for preventing mother-to-child HIV-1 transmission was a key topic.
Implementation:
- Advances in antiretroviral treatment and research from resource-limited settings were highlighted.
- Results from two major Phase III trials of interleukin-2 (IL-2) were presented: ESPRIT and SILCAAT.
- These trials investigated the efficacy of IL-2 in HIV-1 infected patients, particularly those with low CD4+ counts on ART.
Implications:
- The findings contribute to the evolving landscape of HIV-1 management and treatment optimization.
- Interleukin-2 therapy shows potential for improving immune reconstitution in specific HIV-1 patient populations.
- Continued research from diverse settings, including resource-limited areas, is crucial for global HIV-1 control efforts.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

